Stellence Pharmscience Private Limited, a under cirp private limited company, was established on 01 January 1992 in Bangalore, Karnataka, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U85110KA1992PTC012673. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹85.00 Cr and a paid-up capital of ₹43.00 Cr.
Formerly known as Karnataka Chemsyn Limited, Stellence Pharmscience Limited. It upholds a compliant status. Employing 103 professional, Its leadership includes Naveen Kumar Jain (Irp/Rp/Liquidator), Ramachandran Radhakrishnan (Managing Director), Anuradha Ramachandran (Director). Past directors included Francis Pinto, Swati Medatwal, Ramachandran Radhakrishnan. It holds ₹38.00 Cr open charges and ₹31.92 Cr settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at No.456, 1A And 1B Industrial Area Jigani, Bangalore, Karnataka, 562106.
U85110KA1992PTC012673
012673
01 January 1992
₹85.00 Cr
₹43.00 Cr
Roc Bangalore
Unlisted
Under Cirp
Explore comprehensive insights into Stellence Pharmscience Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Naveen Kumar Jain | Irp/Rp/Liquidator | 16 Jul 2024 | Current |
| Ramachandran Radhakrishnan | Managing Director | 23 Aug 2006 | Current |
| Anuradha Ramachandran | Director | 15 May 2019 | Current |
| Akash Mathur | Director | 01 Apr 2020 | Current |
| Lalit Kumar Yadav | Director | 01 Apr 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Feb 2020 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Director | 14 Apr 2012 | Past |
| Pramod Abcsdd | Additional Director | 10 Feb 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2020 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Stellence Pharmscience Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 16.45% decrease. The company also saw a substantial fall in profitability, with a 521.8% decrease in profit. The company's net worth Soared by an impressive increase of 25.01%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Stellence Pharmscience had a promoter holding of 99.67% and a public holding of 0.32%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹380,031,556.00
₹319,225,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2017 | Tata Capital Financial Services Limited | ₹7.50 Cr | Open |
| 28 Jul 2015 | Religare Finvest Limited | ₹4.00 Cr | Open |
| 05 May 2015 | Religare Finvest Limited | ₹1.43 Cr | Open |
| 06 Feb 2015 | Religare Finvest Limited | ₹2.92 Cr | Open |
| 05 Sep 2014 | Religare Finvest Limited | ₹20.65 Cr | Open |
Explore comprehensive loan charge details -
Stellence Pharmscience has a workforce of 103 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Stellence Pharmscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stellence Pharmscience's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Naveen Kumar Jain was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 16 Jul 2024 & has been associated with this company since 1 year 4 months . was recorded as a recent event.
Progress on Sumit Singh was appointed as a Company Secretary was appointed as a Company Secretary on 28 Sep 2023 & has been associated with this company since 2 years 2 months . was documented.
The activity Stellence Pharmscience Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was completed.
Progress on Stellence Pharmscience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Bangalore. was documented.
The activity Akash Mathur was appointed as a Director was appointed as a Director on 01 Apr 2020 & has been associated with this company since 5 years 7 months . was completed.
The activity Lalit Kumar Yadav was appointed as a Director was appointed as a Director on 01 Apr 2020 & has been associated with this company since 5 years 7 months . was completed.
The CIN of Stellence Pharmscience Private Limited is U85110KA1992PTC012673.
Stellence Pharmscience Private Limited is headquartered at No.456, 1A And 1B Industrial Area Jigani, Bangalore, Karnataka, 562106.
Stellence Pharmscience Private Limited was incorporated on 01 January 1992.
The current directors of Stellence Pharmscience Private Limited are
The primary industry of Stellence Pharmscience Private Limited is Manufacturing.
Stellence Pharmscience Private Limited is unlisted.
The authorized capital of Stellence Pharmscience Private Limited is ₹85.00 Cr, and the paid-up capital is ₹43.00 Cr.
The compliance status of Stellence Pharmscience Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX